Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients.
Yoshimura
N
N
Organ Transplant, Kyoto Prefectural University of Medicine, Kawaramachi Kamikyo-ku, Kyoto 602-0841, Japan.
Takahara
S
S
Uchida
K
K
Takahashi
K
K
Oshima
S
S
Toma
H
H
Sonoda
T
T
D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D006949:Hyperlipidemias / Q000453:epidemiology*; D007165:Immunosuppression Therapy / Q000592:standards*; D007564:Japan; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012189:Retrospective Studies; D012449:Safety; D017741:Survivors; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D016559:Tacrolimus